Abstract
Changes in Guillain-Barre Syndrome–Associated Ganglioside Antibody Test Results at a National Clinical Laboratory During the COVID-19 Pandemic (P4-1.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have